Prognostic value of O-(2-[18F]-fluoroethyl)-L-tyrosine PET in relapsing oligodendroglioma.
Florian SchneiderFabian WolpertPaul StolzmannAbdulrahman A AlbatlyDavid KenkelJonathan WellerMichael WellerSpyros S KolliasElisabeth J RushingPatrick Veit-HaibachMartin W HuellnerPublished in: Acta oncologica (Stockholm, Sweden) (2020)
FET-PET may provide added value for the prognostication of relapsing oligodendroglioma in addition to clinical parameters.